Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats

Journal of Hypertension

Volumn 18, Issue 7, 2000, Pages 919-926

  Kh, Reeta ^a   Khullar, Madhu ^a   Kashyap, Manoj ^a   Pandhi, Promila ^a   Uppal, Roma ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Calcium handling; DOCA hypertension; Magnesium; Platelet aggregation

Indexed keywords

CALCIUM; CITRULLINE; DEOXYCORTICOSTERONE ACETATE; MAGNESIUM; NITROGEN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CALCIUM TRANSPORT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEART RATE; HYPERTENSION; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION;

EID: 0033911616     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018070-00014     Document Type: Article

References (39)

1. 1 Williams GH. Hypertensive vascular disease. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL et al. (editors): Harrisons principles of internal medicine, 14th edn, vol. 1. New York: McGraw-Hill; 1998. pp. 1380-1394.
2. 2 Aikawa JK. Magnesium: its biological significance. Boca Raton, FL: CRC Press Inc.; 1981
3. 3 Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13:227-232.
4. 4 Karppanen H. Epidemiologic evidence for considering magnesium deficiency as a risk factor for cardiovascular disease. Magnesium Bull 1990; 12:80-86.
5. 5 Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium and magnesium in women with low habitual intake. Hypertension 1998; 31:131-138.
6. 6 Singh RB, Rastogi SS, Mehta PJ, Cameron EA. Magnesium metabolism in essential hypertension. Acta Cardiol 1989; 44:313-322.
7. 7 Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson JA. Prospective study of nutritional factors, blood pressure and hypertension among US women. Hypertension 1996; 27:1065-1072.
8. 8 Touyz RM, Schiffrin EL. Role of calcium influx and intracellular calcium stores in angiotensin II mediated calcium hyper responsiveness in smooth muscle from spontaneously hypertensive rats. J Hypertens 1997; 15:1431-1439.
9. 9 Neusser M, Tepel M, Grolinski P, Holthues J, Spieker C, Zhu Z, et al. Different calcium storage pools in vascular smooth muscle cells from spontaneously hypertensive and normotensive wistar kyoto rats. J Hypertens 1994; 12:533-538.
10. 10 Touyz RM, Laurant P, Schiffri EL. Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. J Pharmacol Exp Ther 1998; 284:998-1005.
11. 11 Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 1081:188-194.
12. 12 Erne P, Resink TJ, Bolli P, Hefti A, Ritz R, Buhler FR. Free calcium response to adrenaline in patients of normal and hypertensive (untreated and treated) subjects. J Hypertens 1985; 2 (suppl 3):159-161.
13. 13 Fox JEB. The organisation of the platelet contractile protein. In: George JN, Nurden AT, Phillips DR (editors): Platelet membrane glycoproteins. New York, Plenum Press; 1985. pp. 237-298.
14. 14 Zavioco GB, Feinstein MB. Cytoplasmic calcium is controlled in platelets by cyclic AMP antagonism between stimulators and inhibitors of adenylate cyclase. Biochim Biophys Res Commun 1984; 120:579-585.
15. 15 Agranoff BW, Murthy P, Seguin FB. Thrombin induced phosphodiesteratic cleavage of phosphatidyl inositol biophosphate in human platelets. J Biol Chem 1983, 258:2076-2078.
16. 16 Hallam TJ, Sanchez A, Rink TJ. Stimulus-response coupling in human platelets. Biochem J 1984; 218:819-827.
17. 17 Buhler FR, Resink TJ. Platelet abnormalities in the pathophysiology of essential hypertension. Experientia 1988; 44:94-97.
18. 18 Umegaki K, Nakamura K, Ikeda M, Inoue Y, Tomita T. Changes in platelet function due to hypertension: comparison of experimental hypertension with spontaneous hypertension in rats. J Hypertens 1989; 7:13-19.
19. 19 Laurant P, Kantelip JP, Berthelot A. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid salt hypertensive rats but not in normotensive rats. J Nutr 1995; 125:830-841.
20. 20 Bunag RD, Butterfield J. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 1982; 4:898-903.
21. 21 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-929.
22. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138.
23. 23 Rothnagel JA, Rogers GE. Citrulline in proteins from the enzymatic deimination of arginine residues. Methods Enzymol 1984; 107:629-631.
24. 24 Connerky HV, Lau HSC, Briggs AR. Spectrophotometric determination of magnesium by use of methyl thymol blue. Clin Chem 1971; 17:661-662.
25. 25 Overlack A, Zenzen JG, Ressel C, Mullr HM, Stumpe KO. Influence of magnesium on blood pressure and the effect of nifedipine in rats. Hypertension 1987; 9:139-143.
26. 26 Sacks FM. Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combination of potassium, calcium and magnesium supplements in hypertension. Hypertension 1995; 26:950-956.
27. 27 The Trials of Hypertension Prevention Collaborative Research Group. The effects of non pharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase 1. JAMA 1992; 267:1213-1220.
28. 28 Berthelot A, Luthringer C, Meyers E, Exinger A. Disturbance of magnesium metabolism in the spontaneously hypertensive rat. J Am Coll Nutr 1997; 6:329-332.
29. 29 Touyz RM, Milne FJ. Alternations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension. J Hypertens 1995; 13:867-874.
30. 30 Umegaki K, Saegusa H, Kurokawa M, Ichikawa T. Effects of vitamin E administration platelet function and serum lipid peroxides in DOCA-salt hypertensive rats. Thromb Haemost 1991; 85:411-414.
31. 31 Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, et al. Evidence for the distinct G-protein coupled ADP receptors mediating platelet activation. Thromb Haemost 1999; 81:111-117.
32. 32 Tomita T, Umegaki K, Hayashi E, The appearance of exhausted platelets due to a duration of hypertension in stroke prone spontaneously hypertensive rats. Thromb Res 1985; 37:195-200.
33. 33 Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelets activity - an in vitro study. Thromb Haemost 1996; 76:88-93.
34. 2+ in rat vascular smooth muscle cells. Biochim Biophys Acta 1996; 1312:151-157.
35. 35 Laurant P, Moussard C, Alber D, Henry JC, Berthelot A. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats. Prostaglandins Leukotriens Essent Fatty Acids 1992; 47:183-186.
36. 36 Lockette WG, Otsuka Y, Carretero OA. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8 (suppl 2):1161-1166.
37. 37 Goonasekara CDA, Shah V, Rees DD, Dillon MD, Nitric oxide activity in childhood hypertension. Arch Dis Child 1997; 77:11-16.
38. 38 Moncada S. Nitric oxide. J Hypertens 1994; 12 (suppl 10):S35-S39.
39. 39 Nava E, Farre AL, Moreno C, Casado S, Moreau P, Cosentino F, et al. Alterations to the nitric oxide pathway in the spontaneously hypertensive rats. J Hypertens 1998; 16:609-615.